![Tyler Jacks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tyler Jacks
Direktor/Vorstandsmitglied bei
THERMO FISHER SCIENTIFIC, INC.
Vermögen: 11 Mio $ am 31.05.2026
Profil
Tyler E.
Jacks is the founder of T2 Biosystems, Inc., founded in 2006, and Dragonfly Therapeutics, Inc., founded in 2016.
Current jobs include Independent Director at Amgen, Inc. since 2012, Independent Director at Thermo Fisher Scientific, Inc. since 2009, President & Director at Commonwealth Cancer Consortium, Inc. since 2021, and Professor at Massachusetts Institute of Technology since 2007.
Former jobs include Chairman at National Cancer Institute and Director at David H.
Koch Institute for Integrative Cancer Research from 2007 to 2021.
Education history includes an undergraduate degree from Harvard University in 1983 and a doctorate from The University of California, San Francisco in 1988.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.05.2026 | 18’284 ( 0% ) | 6 Mio $ | 31.05.2026 | |
| 20.05.2026 | 9’462 ( 0% ) | 5 Mio $ | 31.05.2026 |
Aktive Positionen von Tyler Jacks
| Unternehmen | Position | Beginn |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Direktor/Vorstandsmitglied | 26.05.2009 |
| AMGEN INC. | Direktor/Vorstandsmitglied | 01.01.2012 |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 01.01.2007 |
Commonwealth Cancer Consortium, Inc.
 Commonwealth Cancer Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit cancer research foundation | Präsident | 01.02.2021 |
Ehemalige bekannte Positionen von Tyler Jacks
| Unternehmen | Position | Ende |
|---|---|---|
David H. Koch Institute for Integrative Cancer Research
 David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research center | Direktor/Vorstandsmitglied | 01.01.2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Vorsitzender | 01.01.2016 |
| T2 BIOSYSTEMS, INC. | Gründer | 01.01.2013 |
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy to stimulate immune responses against cancer | Gründer | - |
Ausbildung von Tyler Jacks
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
97
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research center | Commercial Services |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy to stimulate immune responses against cancer | Health Technology |
Commonwealth Cancer Consortium, Inc.
Commonwealth Cancer Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit cancer research foundation | Commercial Services |
